Heather Palis

发表

Processes and patterns of cocaine use among patients receiving injectable opioids for the treatment of opioid use disorder : a multi-method study

Heather Palis, Heather Palis, 2020 .

Factors Associated with Perceived Abuse in the Health Care System Among Long-Term Opioid Users: A Cross-Sectional Study

M. Schechter, P. Spittal, Heather Palis, 2016, Substance use & misuse.

Feasibility of Applying the Life History Calendar in a Population of Chronic Opioid Users to Identify Patterns of Drug Use and Addiction Treatment

Heather Palis, Kirsten Marchand, Jill Fikowski, 2014, Substance abuse : research and treatment.

Drug overdose and the risk of cardiovascular diseases: a nested case–control study

A. Slaunwhite, F. Scheuermeyer, N. Janjua, 2021, Clinical Research in Cardiology.

Physician Communication in Injectable Opioid Agonist Treatment: Collecting Patient Ratings With the Communication Assessment Tool

M. Schechter, D. Guh, D. Marsh, 2020, Journal of addiction medicine.

Awareness and knowledge of the Good Samaritan Drug Overdose Act among people at risk of witnessing an overdose in British Columbia, Canada: a multi-methods cross sectional study

A. Slaunwhite, S. Barbic, Alissa M. Greer, 2022, Substance Abuse Treatment, Prevention, and Policy.

Men’s and women’s response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder

M. Schechter, A. Anis, D. Guh, 2017, Substance Abuse Treatment, Prevention, and Policy.

Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol

A. Slaunwhite, K. Card, B. Barker, 2020, BMJ Open.

Intention to seek emergency medical services during community overdose events in British Columbia, Canada: a cross-sectional survey

A. Slaunwhite, J. Buxton, Heather Palis, 2022, Substance Abuse Treatment, Prevention, and Policy.

The Role of Gender in Factors Associated With Addiction Treatment Satisfaction Among Long-Term Opioid Users

M. Schechter, P. Spittal, Heather Palis, 2015, Journal of addiction medicine.

in Associated With Addiction Treatment Satisfaction Among Long-Term Opioid Users.

M. Schechter, P. Spittal, Heather Palis, 2015 .

Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: a qualitative study

H. Spence, Jenny McDougall, Heather Palis, 2022, Harm Reduction Journal.

Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with injectable opioid agonist treatment patients

D. Marsh, Heather Palis, Kirsten Marchand, 2021 .

Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report

Heather Palis, E. Oviedo-Joekes, Scott MacDonald, 2021, Harm Reduction Journal.

Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods.

M. Schechter, A. Anis, D. Guh, 2019, Journal of substance abuse treatment.

Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study

A. Slaunwhite, T. Nicholls, Heather Palis, 2022, Substance Abuse Treatment, Prevention, and Policy.

Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling).

N. Bansback, Heather Palis, Kirsten Marchand, 2022, The International journal on drug policy.

Adverse Events During Treatment Induction With Injectable Diacetylmorphine and Hydromorphone for Opioid Use Disorder

M. Schechter, A. Anis, D. Guh, 2019, Journal of addiction medicine.

Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration

A. Slaunwhite, T. Nicholls, Heather Palis, 2022, JAMA network open.

Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome

A. Slaunwhite, R. Singleton, Heather Palis, 2022, Journal of addiction medicine.

Risk of cardiovascular diseases in relation to substance use disorders.

A. Slaunwhite, F. Scheuermeyer, N. Janjua, 2021, Drug and alcohol dependence.

Overdose deaths and the COVID-19 pandemic in British Columbia, Canada.

A. Slaunwhite, J. Buxton, M. Bélair, 2021, Drug and alcohol review.

Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long‐term opioid dependence

M. Schechter, A. Anis, D. Guh, 2018, Drug and alcohol review.

Concurrent use of opioids and stimulants and risk of fatal overdose: A cohort study

A. Slaunwhite, Heather Palis, S. Dobrer, 2022, BMC Public Health.

Longitudinal patterns of cocaine use among patients receiving injectable hydromorphone or diacetylmorphine for the treatment of opioid use disorder: A growth curve modeling approach.

M. Schechter, D. Guh, D. Marsh, 2020, Drug and alcohol dependence.

Drug overdose and the risk of cardiovascular diseases: a nested case–control study

A. Slaunwhite, F. Scheuermeyer, N. Janjua, 2021, Clinical Research in Cardiology.

The Role of Gender in Suicidal Ideation among Long-term Opioid Users

M. Schechter, P. Spittal, Heather Palis, 2017, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Predictors of treatment allocation guesses in a randomized controlled trial testing double-blind injectable hydromorphone and diacetylmorphine for severe opioid use disorder

M. Schechter, A. Anis, D. Guh, 2017 .

Association of Mental Health Services Access and Reincarceration Among Adults Released From Prison in British Columbia, Canada

William A. Rioux, A. Slaunwhite, T. Nicholls, 2022, JAMA network open.

The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder

M. Schechter, A. Anis, D. Guh, 2018, Addictive behaviors reports.

Change in Police Attendance at Overdose Events following Implementation of a Police Non-Notification Policy in British Columbia

A. Slaunwhite, J. Buxton, Heather Palis, 2022, Advances in Public Health.

A multi-methods and longitudinal study of patients' perceptions in injectable opioid agonist treatment: Implications for advancing patient-centered methodologies in substance use research.

M. Schechter, D. Guh, D. Marsh, 2021, Journal of substance abuse treatment.

The relationship between sense of community belonging and self-rated mental health among Canadians with mental or substance use disorders

Heather Palis, Kirsten Marchand, E. Oviedo-Joekes, 2020, Journal of mental health.

Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment

M. Schechter, D. Marsh, Heather Palis, 2021, Substance Abuse Treatment, Prevention, and Policy.

Self-managing illicit stimulant use: A qualitative study with patients receiving injectable opioid agonist treatment.

M. Schechter, D. Marsh, Heather Palis, 2020, Drug and alcohol review.